Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PRTA
Stock Latest News
Ratings
Prothena (PRTA): Partner-Funded, Milestone-Rich Pipeline De-Risks Lead Programs and Supports Buy Rating
4d ago
PRTA
Premium
The Fly
Prothena achieves $50M clinical milestone payment from Novo Nordisk
5d ago
NVO
PRTA
Premium
Company Announcements
Prothena Announces $100 Million Share Repurchase Program
15d ago
8K
PRTA
Premium
The Fly
Prothena announces $100M share repurchase plan
15d ago
PRTA
Premium
The Fly
Prothena expects to end year with $255M in cash, equivalents
15d ago
BMY
NVO
Premium
Company Announcements
Prothena Earnings Call: Pipeline Progress, Risks Ahead
21d ago
PRTA
Premium
Ratings
Prothena: Transformative CYTOPE and TfR Platforms Underpin Long‑Term Upside and Support Buy Rating
22d ago
PRTA
Premium
The Fly
Prothena reports Q4 EPS (40c), consensus (46c)
23d ago
PRTA
Premium
Pre-Earnings
PRTA Earnings this Week: How Will it Perform?
1M ago
PRTA
Premium
Company Announcements
Prothena Board Member Paula Cobb Resigns
3M ago
8K
PRTA
Premium
The Fly
Prothena price target raised to $19 from $11 at Citizens JMP
3M ago
PRTA
Premium
The Fly
Prothena price target raised to $8 from $4 at BofA
4M ago
NVO
CHRO
Premium
Ratings
Sell Rating for Prothena Due to Reliance on Partnered Programs and Uncertainties in Phase 3 Trials
4M ago
PRTA
Premium
Ratings
Promising Outlook for Prothena: Buy Rating Backed by Innovative CYTOPE Platform Advancements
4M ago
PRTA
Premium
Company Announcements
Prothena Shareholders Approve Capital Reduction Proposal
4M ago
8K
PRTA
Premium
The Fly
Prothena announces poster presentation on TDP-43 CYTOPE program
4M ago
PRTA
Premium
Ratings
Prothena’s Coramitug: Promising Phase 2 Results and Buy Rating for ATTR-CM Advancements
4M ago
PRTA
Premium
The Fly
Prothena highlights positive Phase 2 Coramitug data published in AHA journal
4M ago
NVO
PRTA
Premium
The Fly
Prothena price target raised to $30 from $20 at H.C. Wainwright
4M ago
PRTA
Premium
Company Announcements
Prothena Corporation’s Q3 2025 Financial and Clinical Updates
4M ago
PRTA
Premium
The Fly
Prothena reports Q3 EPS (68c), consensus (54c)
4M ago
PRTA
Premium
The Fly
Prothena price target raised to $36 from $15 at Piper Sandler
5M ago
PRTA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
